Skip to Content
Merck
CN
All Photos(1)

Key Documents

View All Documentation

Safety Information

04616

Millipore

Hydrochloric acid concentrate, 0.01N

Dissolution Media Concentrate, Dilute to 6L to conform to USP & EP

Synonym(s):

Hydrochloric acid solution, Hydrogen chloride solution

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
HCl
CAS Number:
7647-01-0
Molecular Weight:
36.46
MDL number:
MFCD00011324

vapor pressure

190 mmHg ( 25 °C)

quality

Dilute to 6L to conform to USP & EP

shelf life

limited shelf life, expiry date on the label

concentration

0.00990-0.01010 N (after dilution)

bp

100 °C (lit.)

SMILES string

Cl

InChI

1S/ClH/h1H

InChI key

VEXZGXHMUGYJMC-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Application

Dissolution Media Concentrates have been formulated to allow quick and easy dilution to a working solution. The label on each bottle indicates the volume of concentrate in the bottle and the volume to which it must be diluted to provide a final media solution that meets the applicable pharmacopoeia specifications. The user friendly format is designed so that each bottle is a single use unit. The instructions below illustrate just how easy it is to prepare the media.

1. Prepare a clean, dry mixing vessel of a suitable size, 6L, 10L or 25L.
2. Add purified water to approximately one third of the required volume i.e. 2L, 3L or 8L.
3. Carefully pour the entire contents of the bottle of concentrate into the vessel.
4. Rinse the bottle with purified water and add rinsing′s to the mixing vessel.
5. Add purified water to the required volume.
6. Mix thoroughly.
7. Measure the pH and proceed if within specification.
8. Adjust pH if necessary.

Pictograms

Corrosion
GHS05

Signal Word

Warning

Hazard Statements

H290

Precautionary Statements

P234 - P390

Hazard Classifications

Met. Corr. 1

Storage Class Code

8B - Non-combustible corrosive hazardous materials

WGK

nwg

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

新产品

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Thomas Krohn et al.
European journal of nuclear medicine and molecular imaging, 42(2), 210-214 (2014-09-25)
To determine the frequency of seemingly pathological retroperitoneal uptake in the location of the coeliac ganglia in patients undergoing [(68)Ga]PSMA-HBED PET/CT. The study included 85 men with prostate cancer referred for [(68)Ga]PSMA-HBED PET/CT. The PET/CT scans were evaluated for the
Sandra Donkervoort et al.
Human mutation, 36(1), 48-56 (2014-09-11)
Collagen 6-related dystrophies and myopathies (COL6-RD) are a group of disorders that form a wide phenotypic spectrum, ranging from severe Ullrich congenital muscular dystrophy, intermediate phenotypes, to the milder Bethlem myopathy. Both inter- and intrafamilial variable expressivity are commonly observed.
Ann Brinkmalm et al.
Molecular neurodegeneration, 9, 53-53 (2014-11-25)
Synaptic degeneration is an early pathogenic event in Alzheimer's disease, associated with cognitive impairment and disease progression. Cerebrospinal fluid biomarkers reflecting synaptic integrity would be highly valuable tools to monitor synaptic degeneration directly in patients. We previously showed that synaptic
Robert Goldstein et al.
European journal of nuclear medicine and molecular imaging, 42(2), 288-301 (2014-11-14)
Human epidermal growth factor receptor-2 (HER2) overexpression is a predictor of response to anti-HER2 therapy in breast and gastric cancer. Currently, HER2 status is assessed by tumour biopsy, but this may not be representative of the larger tumour mass or
Mahsa Sadeghi et al.
British journal of pharmacology, 172(2), 460-468 (2014-01-01)
Tapentadol is a novel analgesic that combines moderate μ-opioid receptor agonism and noradrenaline reuptake inhibition in a single molecule. Both mechanisms of action are involved in producing analgesia; however, the potency and efficacy of tapentadol in individual neurons has not
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service